Related Experiment Video

Updated: May 30, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

A hypertension gene: are we there yet?

Samantha J Lupton1, Christine L Chiu, Joanne M Lind

  • 1Unit of Molecular Physiology, School of Medicine, University of Western Sydney, Australia.

Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies
|July 27, 2011
PubMed

Insights

Essential hypertension, a major risk factor for cardiovascular disease, is influenced by genetics. Research shows multiple common genetic variants, not single gene polymorphisms, contribute to high blood pressure risk.

Area of Science:

  • Cardiovascular research
  • Genetics
  • Pharmacogenomics

Background:

  • Cardiovascular diseases are the leading global cause of mortality.
  • Essential hypertension is a significant risk factor for cardiovascular diseases.
  • Genetic factors contribute substantially to blood pressure variability.

Purpose of the Study:

  • To review candidate gene and genome-wide association studies in hypertension research.
  • To understand the genetic basis of essential hypertension.
  • To explore the potential of pharmacogenomics in personalized hypertension treatment.

Main Methods:

  • Review of candidate gene association studies.
  • Analysis of genome-wide association studies (GWAS).
  • Exploration of genetic polymorphisms related to blood pressure regulation.

Main Results:

  • Identified numerous polymorphisms increasing hypertension risk.
  • Evidence suggests polygenic inheritance for hypertension.
  • No single gene polymorphism universally causes hypertension.

Conclusions:

  • Hypertension results from the cumulative effect of common genetic variants.
  • Personalized pharmacogenomic approaches offer promise for effective hypertension management.
  • Tailored treatments can reduce cardiovascular events and societal disease burden.

More Related Videos

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...